Rocket Lab's $8 Billion Pivot Puts a Promising Backlog in the Shadow of One Big Bet
Published on 08/01/2026 at 14:02 | Redaktion boerse-global.de
Rocket Lab's order book has never looked healthier. Its share price tells a very different story.
The space company closed Friday at €56.30, up a modest 0.36 percent on the day. That surface-level stability masks a brutal stretch: the stock has shed 36.02 percent over the past 30 days and sits 57.92 percent below its May peak of €133.80. On a year-to-date basis, the decline is a comparatively tame 8.46 percent — a gap that underscores just how much of the damage has been concentrated in recent weeks.
A Pivot That Comes With a Price Tag
At the center of the sell-off is the proposed $8 billion acquisition of Iridium Communications, a cash-and-stock deal priced at $54 per share. Management's vision is clear: transform Rocket Lab from a launch provider into a vertically integrated space infrastructure player, using Iridium's recurring service revenue to smooth out the cyclicality of the rocket business.
That logic has its believers. But the market is fixated on the financing burden — and whether the deal stretches the balance sheet before the company's next-generation Neutron rocket can meaningfully contribute to earnings.
Should investors sell immediately? Or is it worth buying Rocket Lab?
The stakes are considerable. Rocket Lab's first-quarter 2026 results showed record revenue of $200.35 million, up 63.5 percent year over year, with a backlog of $2.2 billion. The company still posted a loss of $0.07 per share, and the annualized volatility reading of 96.46 percent reflects just how speculative the equity has become during this transitional phase.
Government Contracts Keep Coming
Operationally, the momentum is hard to argue with. Rocket Lab was recently selected for a US Space Force contract worth $266 million for missile defense testing, and it secured a slot in an IDIQ framework agreement valued at $981 million for the National Space Test and Training Complex, a program that runs through 2032.
NASA has also tapped the company for the PolSIR and TSIS-2 science missions. And on the commercial side, Japanese satellite operator iQPS signed a multi-launch agreement on July 30 covering three dedicated Electron missions starting in late 2027, bringing iQPS's total booked launches to 18. That repeat business from constellation operators provides a degree of revenue visibility the stock price currently fails to reflect.
The Electron rocket itself continues to perform, with the twelfth mission of 2026 — "Ten Owl of Ten" for Synspective — serving as the latest proof point.
The Neutron Question
The bull case rests heavily on the Archimedes engine, which has completed successful test firings and appears on track for Neutron's planned 2026 debut. But the program has already slipped once: a tank crack during a January pressure test pushed the first flight into next year. Any further delays would be costly for a company still operating at a loss.
Technical indicators offer little comfort in the near term. The stock trades 32.46 percent below its 50-day moving average of €83.36, and the RSI sits at 36.7, approaching the oversold threshold of 30. The distance to the 200-day average is 16.43 percent — a sign of how far the price has drifted from its longer-term trend.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
Analysts, for their part, see significant upside. The average price target stands at €99.75, implying a 77.2 percent gain from Friday's close, and several maintain "Moderate Buy" ratings. The gap between that target and the current price is itself a talking point.
What to Watch on August 10
The next catalyst arrives Monday, August 10, 2026, when Rocket Lab reports second-quarter results. Consensus calls for another loss of around $0.07 per share. Investors will be listening for updated guidance on the Iridium deal's closing timeline, the status of the $2.2 billion backlog, and — most critically — any fresh signals on Neutron's schedule and cost trajectory.
If management can lay out a credible path to the profitability it has promised for 2027, the current distance of 72.70 percent from the 52-week low could provide a launching pad for recovery. Should cost overruns or further Neutron setbacks emerge instead, the 200-day average at €67.37 would become the next resistance level to watch.
Ad
Rocket Lab Stock: New Analysis - 1 August
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
